Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development, and therapies
Thursday, August 19, 2021
PM 2:00 Singapore Time (PM 3:00 Korea Time)
The advancement in scientific technologies to trace the spread and the development of various SARS-CoV-2 mutant strains allow us to quickly respond and provide solutions for accurate diagnosis, vaccines, and therapies development. As such, a good understanding and connection to the technologies available to develop the vaccines, therapies, and diagnosis kits are crucial in navigating out of the pandemic.
In this webinar, you will learn:
• The available platforms or systems for us to study the mechanism of action of COVID-19 and the immune responses it triggers
• How to discover and produce potential COVID-19 antibody treatment in a high throughput manner
• The development of diagnostic tools for COVID-19
||Dr. Howwing Leung
Field Application Scientist
|How Wing LEUNG, Ph.D. is the Field Application Scientist, supporting the protein expression and antibody production services at GenScript. Dr. Leung graduated from the National University of Singapore in 2011, majoring in Pharmacology and Neuroscience, and worked as a research fellow in Duke-NUS Medical School thereafter. She has more than 10 years of research experience in molecular biology techniques and extensive knowledge in protein structure modeling, protein expression, and its purification. Using these platforms, she deciphered novel cleavage sites of proteases and their functional implications in stroke upon cleavage of the ionotropic glutamate receptor.